baber/WOPTO huggingface dataset:
Patent NZ-579351-A (NZ)
Title: A method of obtaining seed or settled larvae from bivalve molluscs by placing brooding molluscs into a container with settlement media whereby once the larvae have settled, on growing the settled larvae on farms
Inventor: MAASS-BARRETT TERRENCE JAMES
IPC: A01K21/00
Filed: 2007-03-19
Abstract: A method of obtaining seed or settled larvae from bivalve molluscs and subsequently cultivating the same, is disclosed. The method comprises the steps of: (a) placing one or more larval brood carrying bivalve molluscs and a settlement media into a container, (b) placing the container in an aerated fluid suitable for the settlement of the larval brood, (c) allowing the, or part of, the larval brood to settle on the settlement media, and (d) once the larval brood has settled on the settlement media, placing the settlement media in a farm and growing the molluscs. (62) Divided Out of 553944
Patent NZ-580505-A (NZ)
Title: Modified plant defensin comprising a signal peptide, a mature domain from a Class I defensin and a C-terminal propeptide tail from a Class II plant defensin
Inventor: ANDERSON MARILYN ANNE
IPC: C07K2/00
Filed: 2008-04-18
Abstract: Disclosed is a chimeric plant defensin the defensin being a peptide comprising a signal peptide (S), a mature (M) domain and a C-terminal propeptide tail (T) domain, the M domain being that of a Class I defensin and the T domain being that of a Class II plant defensin. Further disclosed are methods of making transgenic plants which express said chimeric plant defensin for increasing fungus resistance in said plants.
Patent NZ-581541-A (NZ)
Title: Human monoclonal antibodies against CD20
Inventor: RUULS SIGRID
IPC: A61K39/00
Filed: 2003-10-17
Abstract: Disclosed are isolated human monoclonal antibodies which bind to and inhibit human CD20, and related antibody-based compositions and molecules. The human antibodies can be produced by a transfectoma or in a non-human transgenic animal, e.g ., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Patent NZ-582226-A (NZ)
Title: Insertion device with a pivoting action from a first to a second position and longitudinal action to a third position in the direction of insertion.
Inventor: GYRN STEFFEN
IPC: A61M25/06
Filed: 2008-07-03
Abstract: The invention concerns an insertion device (1) for inserting a medical device into the subcutaneous or intramuscular area of a patient. More specifically, this invention relates to an insertion device comprising pivoting and guiding means for moving a penetrating member (9) from a position, where the penetrating member (9) is not pointing into the direction of insertion, to a position, where the penetrating member (9) is pointing into the direction of insertion. The insertion device (1) comprises pivoting means and guiding means providing one or more pivoting movements of the penetrating member (9) from a first position (A), where the penetrating member (9) is not pointing into the direction of insertion, to a second position (C), where the penetrating member (9) is aligned with the direction of insertion, to a third position (D), where the penetrating member (9) protrudes from the housing (15) and the penetrating member (9) is aligned with the direction of insertion. The guiding means provide a straight longitudinal movement of the penetrating member (9) from the second (C) to the third (D) position.
Patent NZ-582508-A (NZ)
Title: Air duct housing with vents adjacent to hot water cyclinder wall for heat pump working fluid circuit
Inventor: GUILFOYLE PHILIP
IPC: F24H6/00
Filed: 2008-08-22
Abstract: Disclosed is a heat pump assembly for a heat pump water heater that allows improved airflow over the components. The components of the working fluid circuit of the heat pump assembly are contained in a housing containing an upper and a lower compartment, the housing has air intake apertures positioned to be proximate the water tank of a water heater when installed and are arranged in a panel which is tapered towards the tank. The upper compartment includes an air heat exchanger and a fan adapted to cause air flow through the air heat exchanger and the lower compartment includes one or more of a compressor and/or a water pump. The air intake apertures are formed in a pair of opposed panels which are inclined at an angle substantially radial to the surface of a cylindrical water tank when installed, whereby the pair of opposed panels form a taper.
Patent NZ-583799-A (NZ)
Title: Transgenic mice comprising a DNA transgene encoding ABeta peptide
Inventor: SCHILLING STEPHAN
IPC: C12N9/10
Filed: 2008-09-12
Abstract: Disclosed is a transgenic non-human animal for overexpressing ABeta peptides comprising cells containing DNA transgenes that encode an ABeta peptide, as defined in the specification. The disclosed transgenes encode at least one of ABetaN3E-42, ABetaN3Q-42, ABetaN3E-40 and ABetaN3Q-40, as defined in the specification.
Patent NZ-584148-A (NZ)
Title: 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
Inventor: CID-NUNEZ JOSE MARIA
IPC: A61K31/47
Filed: 2008-09-12
Abstract: Disclosed is a compound having the formula (I) or a stereochemically isomeric form thereof, wherein R1 is C1-6alkyl; or C1-3alkyl substituted with C3-7cycloalkyl, phenyl, or phenyl substituted with halo, trifluoromethyl or trifluoromethoxy; R2 is halo, trifluoromethyl, C1-3alkyl or cyclopropyl; R3 is hydrogen, halo or trifluoromethyl; R4 is hydrogen, C1-3alkyl, C1-3alkyloxy, hydroxyl C1-3alkyl or tetrahydropyran-2-yloxyC1-3alkyl; N is 1 or 2; X is a covalent bond, O or NR5; R5 is hydrogen, C1-3alkyl or hydroxyl C2-3alkyl; Y is O or CR6(OH); R6 is hydrogen or C1-3alkyl; or R4 and R6 form a radical -CH2-CH2-; or a pharmaceutically acceptable salt or a solvate thereof.
Patent NZ-584582-A (NZ)
Title: Pain relief using electrical stimulation with varying waveforms
Inventor: MARINEO GIUSEPPE
IPC: A61N1/34
Filed: 2007-09-18
Abstract: Disclosed is an apparatus for electrical pain suppression. The apparatus is comprised of a main module, a synthesiser module and one or more channel modules. The main module includes data storage means and data processing means. The data storage means stores signal amplitude parameters Vi corresponding uniquely to a set of sixteen different primitive waveforms S00-S15. Each primitive waveform Si has a periodic and predetermined pattern over time. The data storage means also stores parameters T-packi, Freqi and T-sloti relating to the time duration of a packet, the frequency of a packet and duration of an interval between packets, respectively. The data processing means is adapted and configured to process a data set Bi identifying a sequence of two or more of the different primitive waveforms Si in a time sequence. Each of the primitive waveforms of the sequence is processed on the basis of one or more of the second parameters T-packi, Freqi and T-sloti. The synthesiser module includes means for generating an electric output signal corresponding to the sequence of two or more primitive waveforms. The one or more channel modules Chk are provided to apply the electric output signal to surface receptors in polymodal nerve fibres so that the electric output signal is carried by the polymodal nerve fibres as non-pain information to suppress pain.
Patent NZ-584764-A (NZ)
Title: Composition comprising a cellulose polymer, a sweetener, a plasticiser and a flavour composition
Inventor: WILLOUGHBY DAVID JOHN
IPC: A61K9/30
Filed: 2008-10-30
Abstract: Disclosed is a tablet coating composition including a cellulose polymer, a plasticiser (such as polyethylene glycol), a sweetener, and a powdered flavour composition, the powdered flavour composition including a flavourant associated with a solid carrier (such as dextrin).
Patent NZ-584839-A (NZ)
Title: Antibody purification by cation exchange chromatography
Inventor: LEBRETON BENEDICTE ANDREE
IPC: C07K16/28
Filed: 2008-10-29
Abstract: A method for purifying an antibody from a composition that has a contaminant by the sequential steps of: (a) Loading the composition onto a cation exchange material wherein the composition is at a first pH; (b) Washing the cation exchange material with a first wash buffer at a pH which is greater than that of the composition in (a), wherein the pH of the first wash buffer is from about 6.8 to 9.0; (c) Washing the cation exchange material with a second was buffer at a pH which is less than that of the first wash buffer; and (d) Eluting the antibody from the cation exchange material with an elution buffer at a conductivity which is substantially greater than that of the second wash buffer. The contaminant can be Chinese Hamster Ovary Proteins (CHOP), leached protein A, DNA, aggregated antibody, cell culture media component, garamycin and viral contaminants. The antibody can be an anti-CD20 antibody or an anti-VEGF antibody. The cation exchange material can be cross-linked poly(styrene-divinylbenzene) flow-through particles coated with a polyhydroxylated polymer functionalized with sulfopropyl groups.
Patent NZ-586212-A (NZ)
Title: Mequitazine for treating or preventing pathologies involving histamine h4 receptors
Inventor: CLERC THIERRY
IPC: A61K31/5415
Filed: 2008-12-04
Abstract: Disclosed is the use of 10-[3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, 10-[(3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine or 10-[(3R, 3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, or a pharmaceutically acceptable salt thereof, as sole active principal, to prepare a drug to prevent or treat obstructive bronchopneumopathy.
Patent NZ-586840-A (NZ)
Title: Image coding method and image decoding method
Inventor: DRUGEON VIRGINIE
IPC: H04N19/593
Filed: 2009-01-16
Abstract: Disclosed is an image coding and decoding method. The image encoding method encodes image data for each block. The method includes: a prediction step which predicts an object block and generates a prediction block; a subtraction step which calculates a difference between the object block and the prediction block; an encoding step for encoding the difference calculated by the subtraction step; a decoding step for decoding the encoded difference; and an addition step which adds the decoded difference and the prediction block so as to generate a decoding block. The prediction step has: an edge detection step which detects an edge within the generated decoding block corresponding to a block adjacent to the object block; and a prediction block generation step which generates a prediction block by extrapolating or interpolating the generated decoding image data corresponding to the pixel contained in a block adjacent to the object block along the detected edge direction.
Patent NZ-592985-A (NZ)
Title: Dimeric 1-arylpyrazole derivatives, and their use against ectoparasites
Inventor: MENG CHARLES Q
IPC: A01N43/56
Filed: 2009-11-18
Abstract: ABSTRACT - 592985 The disclosure relates to dimericl-arylpyrazole compounds of formula (I), and salts thereof, and the use of these compounds against ectoparasites such as insects, arthropods and acarina. The resulting compounds may be used in veterinary formulations such as, for example, spot-on and pour-on formulations, which may be used for treatment, controlling and preventing of parasitic infections in warm-blooded animals and birds. A method for controlling pests is also disclosed, wherein a compound of formula (I) or a composition thereof is allowed to act on the pests and/or their environment or on the plants, plant parts, seeds, soils, areas, materials or spaces to be kept free from them.
Patent NZ-596132-A (NZ)
Title: Improved temporary bridge
Inventor: DESCHAMPS GEORGES-PAUL
IPC: E01D15/12
Filed: 2010-03-15
Abstract: A temporary bridge includes two spans each comprising at least three bridge elements (3-5) to be stacked when the bridge is in a first so-called non-deployed position. Said bridge elements (3-5) are pivotably connected to one another, wherein two consecutive bridge elements (3-5) are connected to one another by at least two linking arms (7-9) mounted on the same side edge of said bridge elements (3-5). Two consecutive linking arms (7-9) form a regular parallelogram with the two consecutive bridge elements connected by said arms, which can be deformed such that the movement of one bridge element relative to a bridge element immediately below in the stack of a span in said non-deployed position of said bridge causes the circular translation of said bridge element relative to said bridge element of said span immediately below. For at least one of said spans, at least one of the linking arms (8) is shared by three consecutive bridge elements. The bridge comprises a means for moving each bridge element (3, 4) stacked on another bridge element (4, 5) in the first position between said first position and a second position, referred to as a deployed position, in which the bridge elements are coupled together to form the bridge.
Patent NZ-596693-A (NZ)
Title: Apparatus for lifting a dive tank to a raised position
Inventor: MCCASKEY ROSS MICHAEL
IPC: B63C11/02
Filed: 2011-11-25
Abstract: An apparatus (1) is disclosed for lifting and supporting at least one dive tank and associated gear. The apparatus (1) includes a dive tank holder (2), a lift mechanism (3) connected to the dive tank holder and a base (4). The lift mechanism (3) is at least partly mechanically assisted and is configured to provide a substantially vertical motion only. The lift mechanism (3) is attached to the base (4) which is either free standing and stable when carrying the dive tank(s) or connectable to another support member. The dive tank holder (2) is configured to position the dive tank vertically at a lowermost position, a fitting height or a working height.
Patent NZ-600622-A (NZ)
Title: Compositions and methods for antibodies targeting complement protein c5
Inventor: DIEFENBACH-STREIBER BEATE
IPC: A61K39/395
Filed: 2009-08-03
Abstract: NZ 600622 Disclosed is an isolated antibody or an antigen binding fragment thereof that specifically binds to a human complement C5 protein, said antibody or antigen binding fragment thereof comprising a HCDR1 sequence comprising the sequence of SEQ ID NO: 17, a HCDR2 sequence comprising the sequence of SEQ ID NO: 18, a HCDR3 sequence comprising the sequence of SEQ ID NO: 19, a LCDR1 sequence comprising the sequence of SEQ ID NO: 20, a LCDR2 sequence comprising the sequence of SEQ ID NO: 21, and a LCDR3 sequence comprising the sequence of SEQ ID NO: 22, wherein the sequences are as defined in the complete specification. Further disclosed is the use of said antibody in the treatment of age related macular degeneration, asthma, arthritis, autoimmune heart disease, multiple sclerosis, inflammatory bowel disease, ischemia-reperfusion injuries, Barraquer-Simons Syndrome, hemodialysis, systemic lupus, lupus erythematosus, psoriasis, multiple sclerosis, transplantation, Alzheimer's disease, glomerulonephritis, and MPGN II.
Patent NZ-603879-A (NZ)
Title: Laser cutting system and methods for creating self-retaining sutures
Inventor: GROSS JEFFREY M
IPC: A61B17/04
Filed: 2011-05-04
Abstract: 603879 A laser-machining system and method is disclosed for forming retainers (130) on a suture thread (120). The laser system is preferably a femtosecond laser system which is capable of creating submicron features on the suture thread while preserving strength of the suture thread. The laser-machining system enables creation of retainers and self-retaining suture systems in configurations which are difficult and/or impossible to achieve using mechanical cutting technology.
Patent NZ-611076-A (NZ)
Title: Anti-ngf compositions and use thereof
Inventor: DUTZAR BENJAMIN H
IPC: G01N33/53
Filed: 2011-12-01
Abstract: Disclosed is an anti-human NGF antibody or antibody fragment that selectively inhibits the association of NGF with TrkA, without affecting the association of NGF with p75, wherein the antibody or antibody fragment comprises the CDRs of the sequences as defined in the specification. Also disclosed is the use of the anti-human NGF antibody or antibody fragment for treating a disease or condition associated with NGF expressing cells.
Patent NZ-617402-A (NZ)
Title: Epoxyeicosatrienoic acid analogs and methods of making and using the same
Inventor: IMIG JOHN DAVID
IPC: C07C275/20
Filed: 2012-04-04
Abstract: Disclosed are compounds which are analogs of epoxyeicosatrienoic acid (EET) for example 1-(11-(2-hydroxyphenylthio)undec-5(Z)-enyl)-3-n-pentylurea and compositions containing these compounds. The compounds act as EET agonists and are intended for use as medications in the treatment of drug-induced nephrotoxicity, hypertension and other related conditions. Also disclosed are methods of making and using the compounds and compositions comprising the compounds.
Patent NZ-631601-A (NZ)
Title: Solid forms of a thiophosphoramidate nucleotide prodrug
Inventor: KULDIPKUMAR ANUJ K
IPC: C07H19/06
Filed: 2013-03-11
Abstract: The present application relates to solid state forms, for example, crystalline forms of 2’-C-methyluridine-5’-(O-phenyl-N-(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate (Compound 1), pharmaceutical compositions that can include one or more solid forms of 2’-C-methyluridine-5’-(O-phenyl-N-(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate, and methods of treating or ameliorating diseases and/or conditions with one or more solid forms of 2’-C-methyluridine-5’-(O-phenyl-N-(S)-1-(isopropoxy carbonyl)ethyl)thiophosphoramidate. Also disclosed herein are methods of treating diseases and/or conditions with one or more solid forms of 2’-C-methyluridine-5’-(O-phenyl-N-(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate in combination with one or more other agents.
Patent NZ-721628-A (NZ)
Title: Humidifier
Inventor: HUBY RONALD JAMES
IPC: H05B3/00
Filed: 2012-01-24
Abstract: An air heater coil (140) adapted to heat an airflow within a respiratory device (e.g. air delivery tube 116) comprising a plurality of loops or petals, each loop or petal arranged to overlap an adjacent loop or petal to form a rosette configuration adapted to cover substantially all or most of a cross-sectional area of an air flow path within the respiratory device. Preferably, the plurality of loops or petals are formed of resistive wire.
Patent NZ-729648-A (NZ)
Title: Automated password generation and change
Inventor: BELOTE THOMAS
IPC: H04L9/32
Filed: 2015-07-29
Abstract: An identity management system detects the occurrence of a trigger event, such as a time period expiration, or an action on the identity management system. The identity management system accordingly generates a new password for an account of a user on a third-party service and causes the account of the user on the third-party service to use the new password. The identity management system can also detect a manual user change of a password for a third-party service and cause configuration of client devices of the user to reflect the new password.
Patent NZ-733103-A (NZ)
Title: Method and container transfer installation for placing containers into and removing containers from container storage areas
Inventor: HEIDE CARSTEN
IPC: B65G63/04
Filed: 2015-04-14
Abstract: The invention relates to a method of storing in, and retrieving containers, from a storage facility by way of an automated container transport system and a container transfer installation for carrying out the method. There being a gantry crane (6) and a storage-facility crane (12) that can retrieve from or place containers (1) in a storage facility (3, 15), wherein the gantry crane (6) places containers (1) on pallets (19) or transverse conveying carriages (18) provided on a take-over carriage (8; 8a, 8b) having an upper (1) and lower level (11), for the containers (1) to be transversely transferred to a distributor vehicle (9; 9a, 9b) having an upper and lower level which can move parallel to the storage facility (3, 15), the containers (1) being transferred from the distributor vehicle (9; 9a, 9b) to a stationary transfer station (10) having an upper and lower level to be lifted by the storage facility crane (12) for storage in the storage facility (3, 15). The invention providing an accelerated container transfer process.
Patent NZ-735637-A (NZ)
Title: A rotary vent
Inventor: KRAAL ANDREA TRUDY
IPC: F24F7/02
Filed: 2016-03-23
Abstract: A vent that includes: a rotary head with blades arranged between a top and bottom section of the rotary head; a fixed component to mount the rotary head to a roof of a building, the fixed component having a throat that provides a flow path from inside the building to an interior of the rotary head; a diffuser to split airflow vented from the throat and direct the vented airflow out through the rotary head; and a damper to selectively restrict the airflow passing through the vent. The problem to be solved is the need for a weatherproof roof vent that may be mounted on a sloping or pitched roof. The solution is provided by a damper that acts as a seal and blades that act as a barrier.
Patent NZ-739553-A (NZ)
Title: Mutated protoporphyrinogen ix oxidase (ppx) genes
Inventor: GOCAL GREGORY F W
IPC: A01H5/00
Filed: 2011-08-02
Abstract: Discloses a plant cell comprising mutations to a protoporphyrinogen IX oxidase gene, and plants resistant to herbicide.
Patent NZ-743714-A (NZ)
Title: Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Inventor: SONI PARESH
IPC: A61P9/10
Filed: 2013-06-28
Abstract: In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, use of eicosapentaenoic acid ethyl ester in the manufacture of a medicament for reducing a risk of cardiovascular death, coronary revascularization, and/or unstable angina in a subject having metabolic syndrome and on stable statin therapy, wherein: (a) the subject has been identified as having dyslipidemia, as being on stable statin therapy, and as having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, optionally wherein said subject has established cardiovascular disease or has a high risk of developing cardiovascular disease; and (b) the medicament is formulated for daily administration in an amount to provide about 4 g of the eicosapentaenoic acid ethyl ester per day.
Patent NZ-755366-A (NZ)
Title: Backward-compatible integration of harmonic transposer for high frequency reconstruction of audio signals
Inventor: VILLEMOES LARS
IPC: G10L19/26
Filed: 2018-03-19
Abstract: A method for decoding an encoded audio bitstream is disclosed. The method includes receiving the encoded audio bitstream and decoding the audio data to generate a decoded lowband audio signal. The method further includes extracting high frequency reconstruction metadata and filtering the decoded lowband audio signal with an analysis filterbank to generate a filtered lowband audio signal. The method also includes extracting a flag indicating whether either spectral translation or harmonic transposition is to be performed on the audio data and regenerating a highband portion of the audio signal using the filtered lowband audio signal and the high frequency reconstruction metadata in accordance with the flag.